Epidemiological study to describe Non Small Cell Lung Cancer clinical management patterns in MENA. Lung-EPICLIN/ Gulf - Lung-EPICLIN/G

Study identifier:NIS-OAE-XXX-2011/1

ClinicalTrials.gov identifier:NCT01562665

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Epidemiological study to describe NSCLC clinical management patterns in MENA

Medical condition

Non Small Cells Lung Cancer

Phase

N/A

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Jun 2012

Primary Completion Date: 01 Feb 2015

Study Completion Date: 01 Feb 2015

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Aug 2016 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
All Population	-
Sample of patients will be invited to complete Quality of Life	-

Documents available

EpiclinStudy_Synopsis
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study Information Center

1-877-240-9479

[email protected]

Investigators

Principal Investigator

Kakil Rasul

Hamad Medical Corporation, Doha, Qatar